Detecting Early Cognitive Decline in Alzheimer’s Disease with Brain Synaptic Structural and Functional Evaluation DOI Creative Commons
Samo Ribarič

Biomedicines, Год журнала: 2023, Номер 11(2), С. 355 - 355

Опубликована: Янв. 26, 2023

Early cognitive decline in patients with Alzheimer's (AD) is associated quantifiable structural and functional connectivity changes the brain. AD dysregulation of Aβ tau metabolism progressively disrupt normal synaptic function, leading to loss synapses, decreased hippocampal density early atrophy. Advances brain imaging techniques living have enabled transition from clinical signs symptoms-based diagnosis biomarkers-based diagnosis, techniques, quantitative EEG, body fluids sampling. The hippocampus has a central role semantic episodic memory processing. This function critically dependent on intrahippocampal connections many cortical regions, including perirhinal entorhinal cortex, parahippocampal association regions temporal parietal lobes, prefrontal cortex. Therefore, reflected altered intrinsic networks (aka large-scale networks), memory, default mode, salience networks. narrative review discusses recent critical issues related detecting AD-associated markers high-risk or neuropsychologically diagnosed subjective impairment mild impairment.

Язык: Английский

The China Alzheimer Report 2022 DOI Creative Commons

Ru‐Jing Ren,

Jinlei Qi, Shaohui Lin

и другие.

General Psychiatry, Год журнала: 2022, Номер 35(1), С. e100751 - e100751

Опубликована: Фев. 1, 2022

China's population has rapidly aged over the recent decades of social and economic development as neurodegenerative disorders have proliferated, especially Alzheimer's disease (AD) related dementias (ADRD). AD's incidence rate, morbidity, mortality steadily increased to make it presently fifth leading cause death among urban rural residents in China magnify resulting financial burdens on individuals, families society. The 'Healthy Action' plan 2019-2030 promotes transition from treatment health maintenance for this expanding with ADRD. This report describes epidemiological trends, evaluates burden disease, outlines current clinical diagnosis status delineates existing available public resources. More specifically, examines impact ADRD, including prevalence, mortality, costs, usage care, overall effect caregivers In addition, special presents technical guidance supports prevention AD, provides expertise guide relevant governmental healthcare policy suggests an information platform international exchange cooperation.

Язык: Английский

Процитировано

244

Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications DOI Creative Commons

Yuanwang Jia,

Yu Li, Tieliang Ma

и другие.

Theranostics, Год журнала: 2022, Номер 12(15), С. 6548 - 6575

Опубликована: Янв. 1, 2022

Extracellular vesicles, especially small extracellular vesicles (sEVs) are now accepted as important messengers in cell-to-cell communication and a promising drug delivery platform.They involved nearly all physiological pathological processes disease diagnosis therapy.However, their heterogeneity of physicochemical properties functions is not fully understood, which hinders further clinical applications.To obtain highly bioactive sEVs with both high yield purity, will certainly facilitate future study application.This review informs up-to-date research on frequently-used cutting-edge technologies isolation makes deep comparison analysis different methods, including advantages, limitations applications.Pending questions about the inherent property these well strategies discussed.Additionally, an overview applications treatment, some on-going trials, also reviewed.

Язык: Английский

Процитировано

183

The emerging role of exosomes in Alzheimer’s disease DOI
Tongmei Zhang,

Sehui Ma,

Junkai Lv

и другие.

Ageing Research Reviews, Год журнала: 2021, Номер 68, С. 101321 - 101321

Опубликована: Март 14, 2021

Язык: Английский

Процитировано

106

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases DOI Creative Commons
Yishu Fan, Zhuohui Chen, Mengqi Zhang

и другие.

Journal of Translational Medicine, Год журнала: 2022, Номер 20(1)

Опубликована: Июнь 27, 2022

Central nervous system (CNS) diseases, such as multiple sclerosis, Alzheimer's disease (AD), and Parkinson's (PD), affect millions of people around the world. Great efforts were put in related research, but few breakthroughs have been made diagnostic therapeutic approaches. Exosomes are cell-derived extracellular vesicles containing diverse biologically active molecules secreted by their cell origin. These contents, including nucleic acids, proteins, lipids, amino metabolites, can be transferred between different cells, tissues, or organs, regulating various intercellular cross-organ communications normal pathogenic processes. Considering that cellular environment state strongly impact content uptake efficiency exosomes, detection biological fluids composition analysis potentially offer a multicomponent readout several human diseases. Recently, studies found aberrant secretion exosomes closely to pathogenesis CNS Besides, loading natural cargoes, deliver drugs cross blood brain barrier, making them emerging candidates biomarkers therapeutics for In this review, we summarize discuss advanced research progress pathological processes diseases regarding with neuroinflammation, repair, protein aggregation. Moreover, propose strategies applying diagnosis, early detection, treatment

Язык: Английский

Процитировано

96

Recent progresses in exosome-based systems for targeted drug delivery to the brain DOI
Santosh Bashyal,

Thapa Chhitij,

Sang Kil Lee

и другие.

Journal of Controlled Release, Год журнала: 2022, Номер 348, С. 723 - 744

Опубликована: Июнь 23, 2022

Язык: Английский

Процитировано

86

MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's disease DOI Creative Commons
Ashish Kumar, Yixin Su,

Mitu Sharma

и другие.

Alzheimer s & Dementia, Год журнала: 2023, Номер 19(11), С. 4952 - 4966

Опубликована: Апрель 18, 2023

Brain cell-derived small extracellular vesicles (sEVs) in blood offer unique cellular and molecular information related to the onset progression of Alzheimer's disease (AD). We simultaneously enriched six specific sEV subtypes from plasma analyzed a selected panel microRNAs (miRNAs) older adults with/without cognitive impairment.Total sEVs were isolated participants with normal cognition (CN; n = 11), mild impairment (MCI; MCI conversion AD dementia (MCI-AD; 6), (n 11). Various brain (from neurons, astrocytes, microglia, oligodendrocytes, pericytes, endothelial cells) for miRNAs.miRNAs differentially expressed MCI, MCI-AD, compared CN group clearly distinguished status, an area under curve (AUC) > 0.90 correlated temporal cortical region thickness on magnetic resonance imaging (MRI).miRNA analyses could serve as novel blood-based biomarker AD.Multiple be blood. MicroRNA (miRNA) expression detect (AD) high specificity sensitivity. miRNA (MRI). Altered miRNAs sEVCD31 sEVPDGFRβ suggested vascular dysfunction. predict activation state cell types.

Язык: Английский

Процитировано

49

Plasma biomarkers predict Alzheimer’s disease before clinical onset in Chinese cohorts DOI Creative Commons
Hui Cai,

Yana Pang,

Xiaofeng Fu

и другие.

Nature Communications, Год журнала: 2023, Номер 14(1)

Опубликована: Окт. 24, 2023

Abstract Plasma amyloid-β (Aβ)42, phosphorylated tau (p-tau)181, and neurofilament light chain (NfL) are promising biomarkers of Alzheimer’s disease (AD). However, whether these can predict AD in Chinese populations is yet to be fully explored. We therefore tested the performance plasma 126 participants with preclinical 123 controls 8–10 years follow-up from China Cognition Aging Study. Aβ42, p-tau181, NfL were significantly correlated cerebrospinal fluid counterparts altered AD. Combining successfully discriminated controls. These findings validated a replication cohort including 51 familial mutation carriers 52 non-carriers Familial Disease Network. Here we show that may useful for predicting 8 before clinical onset populations.

Язык: Английский

Процитировано

46

Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade DOI Creative Commons
Saeid Moghassemi, Arezoo Dadashzadeh, Maria João Sousa

и другие.

Bioactive Materials, Год журнала: 2024, Номер 36, С. 126 - 156

Опубликована: Март 2, 2024

Small extracellular vesicles (sEVs) are known to be secreted by a vast majority of cells. These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate signaling pathways in recipient cells through fusion or interaction. nanovesicles possess several desirable properties, making them ideal for regenerative medicine nanomedicine applications. properties include exceptional stability, biocompatibility, wide biodistribution, minimal immunogenicity. However, the practical utilization particularly clinical settings at large scale, is hindered expensive procedures required their isolation, limited circulation lifetime, suboptimal targeting capacity. Despite these challenges, sEVs have demonstrated remarkable ability accommodate various cargoes found extensive applications biomedical sciences. To overcome limitations broaden potential applications, researchers should strive deepen understanding current loading, characterization techniques. Additionally, acquiring fundamental knowledge about origins employing state-of-the-art methodologies expand research scope. This review provides comprehensive overview exosome-based strategies diverse domains, encompassing cancer therapy, immunotherapy, biomarker Furthermore, we emphasize immense exosomes medicine.

Язык: Английский

Процитировано

35

Isolation and usage of exosomes in central nervous system diseases DOI Creative Commons
Wenjing Wang, Hong Sun,

Huijuan Duan

и другие.

CNS Neuroscience & Therapeutics, Год журнала: 2024, Номер 30(3)

Опубликована: Март 1, 2024

Abstract Background Exosomes are vesicles secreted by all types of mammalian cells. They characterized a double‐layered lipid membrane structure. serve as carriers for plethora signal molecules, including DNA, RNA, proteins, and lipids. Their unique capability effortlessly crossing the blood–brain barrier underscores their critical role in progression various neurological disorders. This includes, but is not limited to, diseases such Alzheimer's, Parkinson's, ischemic stroke. Establishing stable mature methods isolating exosomes prerequisite study biomedical significance. The extraction technologies include differential centrifugation, density gradient size exclusion chromatography, ultrafiltration, polymer coprecipitation, immunoaffinity capture, microfluidic, so forth. Each technology has its own advantages disadvantages, standards have been unified internationally. Aims review aimed to showcase recent advancements exosome isolation techniques thoroughly compare disadvantages different methods. Furthermore, significant research progress made using diagnosing treating central nervous system (CNS) emphasized. Conclusion varying result differences concentration, purity, exosomes. efficient separation facilitates widespread application, particularly diagnosis treatment CNS diseases.

Язык: Английский

Процитировано

21

Exosomes Engineering and Their Roles as Therapy Delivery Tools, Therapeutic Targets, and Biomarkers DOI Open Access

Nika Kučuk,

Mateja Primožič,

Željko Knez

и другие.

International Journal of Molecular Sciences, Год журнала: 2021, Номер 22(17), С. 9543 - 9543

Опубликована: Сен. 2, 2021

Exosomes are becoming increasingly important therapeutic biomaterials for use in a variety of applications due to their unique characteristics, especially the ineffectiveness and cytotoxicity some existing therapies synthetic nanocarriers. They highly promising as carriers drugs, genes, other agents that can be incorporated into interior or onto surface through various modification techniques improve targeting abilities. In addition, they biocompatible, safe, stable. The review focuses on different types exosomes methods preparation, including incorporation kinds cargo, drug delivery purposes. particular, importance effectiveness vehicles applications, diseases disorders such cancer treatment, cardiovascular neurodegenerative diseases, emphasized. Administration routes body also included. A novelty article is emphasis global companies already successfully developing testing biomaterials, with focus most influential ones. Moreover, comparison advantages disadvantages exosome production summarized first time.

Язык: Английский

Процитировано

105